Matthew Budd

1.0k total citations
21 papers, 772 citations indexed

About

Matthew Budd is a scholar working on Molecular Biology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Matthew Budd has authored 21 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Infectious Diseases and 3 papers in General Health Professions. Recurrent topics in Matthew Budd's work include HIV/AIDS Research and Interventions (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Matthew Budd is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Matthew Budd collaborates with scholars based in Canada, United States and United Kingdom. Matthew Budd's co-authors include Mary L. Efron, Kay Tanaka, K. J. Isselbacher, David C. McClelland, Joan Z. Borysenko, Herbert Benson, Caroline McLeod, John D. Crawford, Kurt J. Isselbacher and Lewis B. Holmes and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Matthew Budd

20 papers receiving 705 citations

Peers

Countries citing papers authored by Matthew Budd

Since Specialization

Citations

This map shows the geographic impact of Matthew Budd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Budd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Budd more than expected).

Fields of papers citing papers by Matthew Budd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Budd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Budd. The network helps show where Matthew Budd may publish in the future.

Co-authorship network of co-authors of Matthew Budd

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Budd. A scholar is included among the top collaborators of Matthew Budd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Budd. Matthew Budd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strategies for optimizing CITE-seq for human islets and other tissues 2023 ·Frontiers in Immunology ·(unknown), Matthew Budd, (unknown), (unknown), Julia Murphy, Sabine Ivison, C. Bruce Verchere, Megan K. Levings, Sarah Q. Crome	6
2	Probabilistic Planning for AUV Data Harvesting from Smart Underwater Sensor Networks 2022 ·2022 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) ·Matthew Budd, Georgios Salavasidis, (unknown), Catherine A. Harris, Alexander B. Phillips, Paul Duckworth, Nick Hawes, Bruno Lacerda	1
3	Interactions between islets and regulatory immune cells in health and type 1 diabetes 2021 ·Diabetologia ·Matthew Budd, (unknown), (unknown), Sarah Q. Crome, C. Bruce Verchere, Megan K. Levings	10
4	Markov Decision Processes with Unknown State Feature Values for Safe Exploration using Gaussian Processes 2020 ·Research Explorer (The University of Manchester) ·Matthew Budd, Bruno Lacerda, Paul Duckworth, Andrew West, Barry Lennox, Nick Hawes	12
5	Effect of an interactive text-messaging service on patient retention during the first year of HIV care in Kenya (WelTel Retain): an open-label, randomised parallel-group study 2018 ·The Lancet Public Health ·Mia L. van der Kop, Samuel Muhula, (unknown), Lehana Thabane, Lawrence Gelmon, (unknown), (unknown), (unknown), Matthew Budd, Carlo A. Marra, Anik R. Patel, Sarah Karanja, David Ojakaa, Edward J. Mills, Anna Mia Ekström, Richard Lester	50
6	A Monochrome Multiplex Real-Time Quantitative PCR Assay for the Measurement of Mitochondrial DNA Content 2018 ·Journal of Molecular Diagnostics ·(unknown), Matthew Budd, David Deng, (unknown), Hélène C. F. Côté	15
7	The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial 2018 ·European Respiratory Journal ·James C. Johnston, Mia L. van der Kop, Kirsten Smillie, Gina Ogilvie, Fawziah Marra, Mohsen Sadatsafavi, Kamila Romanowski, Matthew Budd, Jan Hájek, Victoria J. Cook, Richard Lester	29
8	Blood Mitochondrial DNA Content in HIV-Exposed Uninfected Children with Autism Spectrum Disorder 2018 ·Viruses ·Matthew Budd, Kristina Calli, Lindy Samson, Jennifer Bowes, (unknown), John C. Forbes, Ari Bitnun, Joel Singer, Fatima Kakkar, Ariane Alimenti, Evelyn J. Maan, M. E. Suzanne Lewis, (unknown), Hélène C. F. Côté, Jason Brophy	18
9	Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children 2018 ·AIDS ·Micah Piske, Matthew Budd, (unknown), Evelyn J. Maan, Laura Sauvé, John C. Forbes, Ariane Alimenti, Patricia A. Janssen, Hélène C. F. Côté	19
10	Folate deficiency in an unselected population in Calgary, Alberta and its relationship with red blood cell macrocytosis 2015 ·BMC Research Notes ·Matthew Budd, Christopher Naugler	1
11	Pilot study: Retreat intervention predicts improved quality of life and reduced psychological distress among breast cancer patients 2011 ·Complementary Therapies in Clinical Practice ·Elizabeth J. Vella, Matthew Budd	19
12	Behavioural Medicine Group Intervention for High-Utilising Somatising Patients 1999 ·Disease Management & Health Outcomes ·Steven E. Locke, (unknown), Debra S. Morley, Caroline McLeod, Matthew Budd, (unknown)	1
13	Treatment of somatization in primary care 1997 ·General Hospital Psychiatry ·Caroline McLeod, Matthew Budd, David C. McClelland	58
14	A Study of the Effectiveness of Two Group Behavioral Medicine Interventions for Patients with Psychosomatic Complaints 1990 ·Behavioral Medicine ·(unknown), Matthew Budd, Joan Z. Borysenko, David C. McClelland, Herbert Benson	126
15	Book ReviewHead First: The biology of hope 1990 ·New England Journal of Medicine ·Matthew Budd	1
16	Isovaleric Acidemia 1967 ·New England Journal of Medicine ·Matthew Budd, Kay Tanaka, Lewis B. Holmes, Mary L. Efron, John D. Crawford, Kurt J. Isselbacher	81
17	Isovaleric acidemia: A new genetic defect of leucine metabolism 1966 ·The Journal of Pediatrics ·Lewis B. Holmes, Kay Tanaka, Matthew Budd, Kurt J. Isselbacher, Mary L. Efron, John D. Crawford	22
18	Evaluation of Intradermal Skin Tests in Penicillin Hypersensitivity 1964 ·JAMA ·Matthew Budd, Charles W. Parker, Carl W. Norden	32
19	ANTIBIOTIC-INDUCED MODIFICATION OF RESISTANCE TO NASAL COLONIZATION BY STAPHYLOCOCCUS AUREUS. 1964 ·PubMed ·Matthew Budd, John R. Boring, Philip S. Brachman	1
20	Comparison of the Nucleic Acid, Total Nitrogen, and Protein Nitrogen Levels of Normal and Tumor Tissue under Similar Growth Conditions. 1959 ·PLANT PHYSIOLOGY ·(unknown), Matthew Budd, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact